Section one: Contracting authority/entity
one.1) Name and addresses
Gateshead Health NHS Foundation Trust
Queen Elizabeth Hospital, Sheriff Hill
Gateshead
NE96SX
Telephone
+44 1914452801
Country
United Kingdom
Region code
UKC22 - Tyneside
Justification for not providing organisation identifier
Not on any register
Internet address(es)
Main address
Section two: Object
two.1) Scope of the procurement
two.1.1) Title
Biochemistry Referrals - UHC
two.1.2) Main CPV code
- 85145000 - Services provided by medical laboratories
two.1.3) Type of contract
Services
two.1.4) Short description
Biochemistry referral testing.
Section six. Complementary information
six.6) Original notice reference
Notice number: 2025/S 000-041383
Section seven. Changes
seven.1.2) Text to be corrected in the original notice
Section number
VI.3
Instead of
Text
This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Procurement Act 2023 do not appl to this award. The standstill period begins on the day after the publication of this notice.
Representations by providers must be made to decision makers by 29th July 2025. This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR.
Decision makers: Dr Kate MacDougall
Conflicts of Interest: None declared
Clinical Criteria: Second Opinion are requested from experts in a chosen speciality that are employed in a UKAS accredited laboratory and participate in EQA for that speciality.
Turnaround times for results are also a consideration for utilising the referral service with this provider. Test referrals are made to UKAS accredited laboratories with acceptable clinical
interpretation, availability of clinical advice and turnarounds that facilitate compliance with RCPath guidelines. Referrals are often made in accordance with established regional referral
pathways in line with MDT arrangements for tertiary specialities. Genomic test referrals are made in accordance with genomic hub guidelines.
Rationale: Existing service provider, will likely satisfy the proposed contract to a sufficient standard. No considerable changes anticipated.
Read
Text
This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Procurement Act 2023 do not apply to this award. The standstill period begins on the day after the publication of this notice. Representations by providers must be made to decision makers by 4th August 2025. This
contract has not yet formally been awarded; this notice serves as an intention to award under the PSR.
Decision Makers: Dr David Kennedy
Conflicts of Interest: None declared
Clinical criteria: Suitable / compatible analytical methodology, appropriate reference ranges and clinical comments, availability of useful clinical advice (based on national reputation, and/or experience and/or user feedback)
UKAS Accredited (or ETS applied for and pending assessment)